IL75122A - 3-methyl-5-(tetrahydro-6-oxopyridazin-3-yl)indoline derivatives,their preparation and use - Google Patents

3-methyl-5-(tetrahydro-6-oxopyridazin-3-yl)indoline derivatives,their preparation and use

Info

Publication number
IL75122A
IL75122A IL75122A IL7512285A IL75122A IL 75122 A IL75122 A IL 75122A IL 75122 A IL75122 A IL 75122A IL 7512285 A IL7512285 A IL 7512285A IL 75122 A IL75122 A IL 75122A
Authority
IL
Israel
Prior art keywords
oxopyridazin
tetrahydro
methyl
preparation
indoline derivatives
Prior art date
Application number
IL75122A
Other languages
English (en)
Other versions
IL75122A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL75122A0 publication Critical patent/IL75122A0/xx
Publication of IL75122A publication Critical patent/IL75122A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IL75122A 1984-05-14 1985-05-07 3-methyl-5-(tetrahydro-6-oxopyridazin-3-yl)indoline derivatives,their preparation and use IL75122A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61021084A 1984-05-14 1984-05-14

Publications (2)

Publication Number Publication Date
IL75122A0 IL75122A0 (en) 1985-09-29
IL75122A true IL75122A (en) 1989-02-28

Family

ID=24444125

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75122A IL75122A (en) 1984-05-14 1985-05-07 3-methyl-5-(tetrahydro-6-oxopyridazin-3-yl)indoline derivatives,their preparation and use

Country Status (20)

Country Link
EP (1) EP0161918B1 (xx)
JP (1) JPH0643417B2 (xx)
KR (1) KR870000274B1 (xx)
AR (1) AR241531A1 (xx)
AT (1) ATE54915T1 (xx)
AU (1) AU577372B2 (xx)
CA (1) CA1248099A (xx)
DE (1) DE3578822D1 (xx)
DK (1) DK207785A (xx)
EG (1) EG17342A (xx)
ES (1) ES8609308A1 (xx)
GR (1) GR851121B (xx)
HU (1) HU194873B (xx)
IL (1) IL75122A (xx)
MY (1) MY101520A (xx)
NZ (1) NZ212023A (xx)
PH (1) PH21862A (xx)
PT (1) PT80414B (xx)
SU (1) SU1486060A3 (xx)
ZA (1) ZA853440B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591591A (en) * 1984-03-08 1986-05-27 Eli Lilly And Company Pyridazinone derivatives as inotropic agents
DE3631085A1 (de) * 1986-09-12 1988-03-24 Boehringer Mannheim Gmbh Heterocyclisch substituierte indolinone, verfahren zu ihrer herstellung, arzneimittel sowie zwischenprodukte
DE3706427A1 (de) * 1987-02-27 1988-09-08 Boehringer Mannheim Gmbh Neue substituierte 3h-indole, zwischenprodukte, verfahren zu ihrer herstellung sowie arzneimittel
US5196416A (en) * 1987-08-28 1993-03-23 Eli Lilly And Company Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water
ES2037230T3 (es) * 1987-08-28 1993-06-16 Eli Lilly And Company Composiciones activadoras de la penetracion.
DE68917485T2 (de) * 1988-01-23 1995-02-09 Kyowa Hakko Kogyo Kk Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP6251038B2 (ja) 2011-03-01 2017-12-20 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcアゴニストの調製方法
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
DE3124699A1 (de) * 1981-06-24 1983-01-13 Basf Ag, 6700 Ludwigshafen Neue 2-aryl-3,4-diaza-bicyclo(4.n.0.)alken-(2)-one-(5),verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS588016A (ja) * 1981-07-06 1983-01-18 Mitsubishi Chem Ind Ltd 強心剤

Also Published As

Publication number Publication date
KR850008166A (ko) 1985-12-13
HUT37783A (en) 1986-02-28
CA1248099A (en) 1989-01-03
PT80414B (en) 1987-04-16
PT80414A (en) 1985-06-01
NZ212023A (en) 1988-04-29
EP0161918A3 (en) 1986-11-20
ES543078A0 (es) 1986-09-01
ATE54915T1 (de) 1990-08-15
PH21862A (en) 1988-03-25
DK207785D0 (da) 1985-05-10
HU194873B (en) 1988-03-28
EP0161918B1 (en) 1990-07-25
GR851121B (xx) 1985-11-25
DK207785A (da) 1985-11-15
IL75122A0 (en) 1985-09-29
EG17342A (en) 1991-03-30
JPS6122080A (ja) 1986-01-30
KR870000274B1 (ko) 1987-02-23
EP0161918A2 (en) 1985-11-21
MY101520A (en) 1991-11-30
AU577372B2 (en) 1988-09-22
AR241531A1 (es) 1992-08-31
ZA853440B (en) 1986-12-30
JPH0643417B2 (ja) 1994-06-08
AU4240585A (en) 1985-11-21
DE3578822D1 (de) 1990-08-30
ES8609308A1 (es) 1986-09-01
SU1486060A3 (ru) 1989-06-07

Similar Documents

Publication Publication Date Title
IL77198A (en) 13beta-milbemycin derivatives,their preparation and their use as pesticides
EP0163550A3 (en) New mitomycin derivatives, preparation thereof and pharmaceutical compositions containing them
IL75122A (en) 3-methyl-5-(tetrahydro-6-oxopyridazin-3-yl)indoline derivatives,their preparation and use
IL83198A (en) Benzenesulphonamidoindanyl derivatives,their preparation and medicaments containing them
IL77140A0 (en) 5-azolylacetoxymilbemycin derivatives,their preparation and their use as pesticides
IL77310A (en) 13beta-acyloxymilbemycin derivatives,their preparation and their use as pesticides
IL76854A (en) Oxindole derivatives
IL77650A (en) 13beta-alkylmilbemycin derivatives,their preparation and their use as pesticides
IL76392A0 (en) 13-halo-and 13-hydroxymilbemycine derivatives,their preparation and their use as pesticides
DE3560679D1 (en) 4-hydroxy-2h-1-benzothiopyran-2-one derivatives, their preparation and uses
DE3572977D1 (en) Indole derivatives, their preparation, their use as medicines and compositions containing them
IL79853A0 (en) Azolyl-cyclopropyl-ethanol derivatives,processes for their preparation and their use
IL74133A0 (en) Azolyl-aryl-alkanol derivatives,processes for their preparation and their use
ZA855072B (en) Heterocyclic pharmaceutical compounds,preparation and use
ZA879235B (en) Peridone derivatives,and their preparation and use
ZA864888B (en) 5-substituted-6-aminopyrimidine derivatives,composition and uses
AU578739B2 (en) Vinyltetrazolylphenyl derivatives, their preparation and their use
DE3365480D1 (en) Oxacephalosporin derivatives, their preparation and use
IL86796A0 (en) Peptide derivatives,their preparation and their use
IL76214A0 (en) Sulphonylisourea derivatives,their preparation and their use as herbicides
IL75711A0 (en) Imidazo-pyrrolo-pyridine derivatives,their preparation and their use as herbicides
AU550725B2 (en) 17,18-dehydrovincaminol derivatives and their preparation
EG16141A (en) 1,2,4-triazol-1-yl-propionitrile derivatives their preparation and use
IL76217A0 (en) Sulphonylguanidinopyrimidine derivatives,their preparation and their use as herbicides
GB2213480B (en) Dioxazocine derivatives, their preparation and compositions containing them